A new international research study will focus on treatment strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with known or suspected COVID-19.

Heart bypass patients experience better outcomes when the surgeon uses a segment of the radial artery instead of one from the saphenous vein, according to a new analysis of more than 1,000 patients.   

The COVID-19 pandemic has changed the practice of cardiology as we know it, leading to supplies shortages, delayed procedures, and an at-risk patient population fearful of the road ahead. How has the outbreak affected cath labs?

As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.

Three-year data from the BIOFLOW-V trial, presented Feb. 23 at the 2020 CRT Congress in National Harbor, Md., reinforce the status of Biotronik’s Orsiro drug-eluting stent as superior to the popular Xience stent.

Researchers on the EXCEL trial have been accused of withholding key mortality data when they first published results suggesting stents were as safe as open-heart surgery in treating patients with left main disease.

Philips is launching a new randomized controlled trial—dubbed DEFINE GPS—to assess patient outcomes after PCI guided by instant wave-Free Ratio measurements and angiograms. 

A review published in Circulation: Cardiovascular Interventions Jan. 24 suggests adjunctive coronary atherectomy is a clinically useful and effective tool for treating severely calcified coronary lesions—but, in reality, it’s rarely used.